Author(s): Sampaio,Raimunda Nonata Ribeiro ; Ferreira,Marina Freitas ; Martins,Sofia Sales ; Motta,Jorgeth de Oliveira Carneiro da
Date: 2021
Origin: Oasisbr
Subject(s): Allopurinol; Antimony; Recurrence; Therapy; Diffuse cutaneous leishmaniasis
Document details
Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis,
Description
Abstract Diffuse cutaneous leishmaniasis is a rare universal disease associated with an inadequate host cell immune response, caused by different species: infantum, aethiopica, major, mexicana, and others, which presents the challenge of a poor therapeutic response. In Brazil, it is caused by L. amazonensis. A case confirmed by histopathology with an abundance of vacuolated macrophages full of amastigotes and lymphocyte scarcity, identified by RFLP-ITS1PCR and in vitro decrease and exhaustion of the host cell immune response to L. amazonensis antigen, was treated early (3 months after the onset) with Glucantime (2 months) and allopurinol (29 months) with clinical cure, after a follow-up for 30 months after treatment.
Document Type
Journal article
Language English
Language English
